These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1371816)

  • 41. Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor.
    Fewtrell MS; Kinsey SE; Williams DM; Bishop NJ
    Br J Haematol; 1997 Jun; 97(4):734-6. PubMed ID: 9217170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection.
    Hester JP; Dignani MC; Anaissie EJ; Kantarjian HM; O'Brien S; Freireich EJ
    J Clin Apher; 1995; 10(4):188-93. PubMed ID: 8770711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sea-blue histiocytes in the bone marrow of a boy with severe congenital neutropenia associated with G6PC3 mutation.
    Tavil B; Cetin M; Gumruk F
    Br J Haematol; 2014 May; 165(4):426. PubMed ID: 24446813
    [No Abstract]   [Full Text] [Related]  

  • 44. The investigation and management of chronic neutropenia in children.
    James RM; Kinsey SE
    Arch Dis Child; 2006 Oct; 91(10):852-8. PubMed ID: 16990357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of autoimmune neutropenia with recombinant human granulocyte colony-stimulating factor.
    Carulli G
    Ann Hematol; 1998 Feb; 76(2):93-4. PubMed ID: 9540766
    [No Abstract]   [Full Text] [Related]  

  • 46. Paroxysmal nocturnal hemoglobinuria: efficacy of prolonged treatment with granulocyte colony-stimulating factor.
    Jégo P; Le Strat A; Girard L; Sébillot M; Grosbois B; Le Blay R; Drénou B
    Blood; 1997 Oct; 90(7):2841-3. PubMed ID: 9326254
    [No Abstract]   [Full Text] [Related]  

  • 47. Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor.
    Jones EA; Bolyard AA; Dale DC
    JAMA; 1993 Sep; 270(9):1132-3. PubMed ID: 7688828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulocyte colony-stimulating factor for neutropenia in neonatal sepsis.
    Nankervis CA; Seguin JH
    Arch Pediatr Adolesc Med; 1995 Feb; 149(2):218-9. PubMed ID: 7531572
    [No Abstract]   [Full Text] [Related]  

  • 49. A new low for an old high: neutropenia induced by levamisole-adulterated cocaine.
    Van Wieren A; Kapoor M; Rao P; Gardner R
    Med Health R I; 2010 Oct; 93(10):320-1. PubMed ID: 21284272
    [No Abstract]   [Full Text] [Related]  

  • 50. Acute monocytic leukemia in a patient with severe congenital neutropenia after treatment with recombinant human granulocyte colony-stimulating factor.
    Nibu K; Yanai F; Hirota O; Hatazoe M; Yamaguchi S; Akamatsu M; Kikuchi M; Morimoto Y; Kuwano A
    J Pediatr Hematol Oncol; 1996 Nov; 18(4):422-4. PubMed ID: 8888760
    [No Abstract]   [Full Text] [Related]  

  • 51. Leukemic transformation in patients with severe congenital neutropenia.
    Banerjee A; Shannon KM
    J Pediatr Hematol Oncol; 2001 Nov; 23(8):487-95. PubMed ID: 11878775
    [No Abstract]   [Full Text] [Related]  

  • 52. Phenotypic analysis of blood neutrophils in a patient with chronic idiopathic neutropenia and favorable response to G-CSF treatment.
    Zarco MA; Ribera JM; Villamor N; Millá F; Juncá J; Florensa L; Feliu E
    Am J Hematol; 1996 Jan; 51(1):96-7. PubMed ID: 8571950
    [No Abstract]   [Full Text] [Related]  

  • 53. rhG-CSF resistant neutropenia in SLE.
    Frosch M; Roth J; Harms E
    Ann Rheum Dis; 1997 Jun; 56(6):396. PubMed ID: 9227175
    [No Abstract]   [Full Text] [Related]  

  • 54. Failure of granulocyte colony-stimulating factor in alloimmune neonatal neutropenia.
    Bedu A; Baumann C; Rohrlich P; Duval M; Fenneteau O; Cartron J
    J Pediatr; 1995 Sep; 127(3):508-9. PubMed ID: 7544828
    [No Abstract]   [Full Text] [Related]  

  • 55. Development of Kawasaki syndrome in autoimmune neutropenia after treatment with granulocyte colony-stimulating factor.
    Ueno K; Nomura Y; Arata M; Maruyama S; Tanabe T; Eguchi T; Kawano Y
    Pediatr Int; 2011 Jun; 53(3):388-90. PubMed ID: 21696506
    [No Abstract]   [Full Text] [Related]  

  • 56. Granulocyte colony-stimulating factor and congenital neutropenia--risk of leukemia?
    Corey SJ; Wollman MR; Deshpande RV
    J Pediatr; 1996 Jul; 129(1):187-8. PubMed ID: 8757597
    [No Abstract]   [Full Text] [Related]  

  • 57. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia.
    Mori M; Nonoyama S; Neubauer M; Mitsuda T; Kosuge K; Yokota S
    J Pediatr Hematol Oncol; 2000; 22(3):288-9. PubMed ID: 10864066
    [No Abstract]   [Full Text] [Related]  

  • 58. A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit.
    Christensen RD; Calhoun DA; Rimsza LM
    Clin Perinatol; 2000 Sep; 27(3):577-601. PubMed ID: 10986630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines for pediatric management of severe chronic neutropenia.
    Dale DC; Boxer LA
    Am J Hematol; 2012 Feb; 87(2):133. PubMed ID: 22237723
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor.
    Katoh M; Shikoshi K; Takada M; Umeda M; Tsukahara T; Kitagawa S; Shirai T
    Ann Hematol; 1993 Oct; 67(4):201-2. PubMed ID: 7692983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.